Bacteriological behavior of chronic otitis media in patients diagnosed in Otorhinolaryngology Service
Abstract
Introduction: chronic otitis media is still an important cause of morbidity and hearing impairment in children and adults worldwide. The choice of antibiotic treatment in different stages of chronic otitis media is constantly being revised due to possible variations in antibiotic susceptibility of organisms involved.
Objective: describe the bacteriological behavior of chronic otitis media in “Dr. Antonio Luaces Iraola” Universitary Hospital of Ciego de Ávila where, from March 2011 to December 2013, an observational descriptive cross-sectional study of patients diagnosed with chronic otitis media was carried out.
Results: the highest incidence of the disease was in the ages of 6-15 years. Bacteriological behavior occurs as follows: germs such as Pseudomonas aeruginosa, Escherichia coli and Proteus were the bacteria most frequently found, followed by Staphylococcus aureus and Klepsiella. Antibiotics with more sensitive were amikacin, being sensitive in 148 cases, gentamicin, kanamycin, chloramphenicol, claforan (cefotaxime), rocephin (ceftriaxone), norfloxacin and sulfaprin. Antibiotics with increased antimicrobial resistance as the most common germs were: Peudomonas aeruginosa: ampicillin, kanamycin, chloramphenicol and sulfaprin. Escherichia coli: ampicillin and sulfaprin. Proteus mirabilis: ampicillin, kanamycin, chloramphenicol and sulfaprín. Staphylococcus aureus: ampicillin and erythromycin. Klepsiella: ampicillin, rocephin and claforan. Conclusions: a high incidence of chronic otitis media just as well as a variety of germs with sensitivity and resistance to antimicrobial therapy was found.
Downloads
Published
How to Cite
Issue
Section
License
MediCiego does not apply publication charges. The journal is available in open access without restrictions, in compliance with the international policy on open access to information for the exchange of global knowledge.
The authors will retain their copyright and guarantee the journal the right of first publication of their work. MediCiego is licensed under the Creative Commons Attribution-NonCommercial 4.0 International license (CC BY-NC 4.0) https://creativecommons.org/licenses/by-nc/4.0/deed.es_ES), so it is allowed to copy, reproduce, distribute, publicly communicate the work and generate derivative works, as long as the original author is cited and acknowledged. However, it is not allowed to use the original work for commercial or lucrative purposes.
Authors must sign a copyright agreement through an affidavit of authorship and originality, before publishing.
The authors authorize the publication of their writings; they retain the copyright, and assign to the journal all the rights protected by the Copyright Law that governs Cuba, and implies the edition to disseminate the work.
Likewise, they may establish additional agreements for the non-exclusive distribution of the version of the work published in the journal (for example, placing it in an institutional repository or publishing it in a book), with the recognition of having been first published in this journal.
Declaration of authorship: download here the Affidavit
